TOP TIERMARKET NEWSWIRE
News & sentiment

KYVERNA THERAPEUTICS (KYTX) — News & AI sentiment

KYVERNA THERAPEUTICS (KYTX) news roundup. 4 stories in the past week, 10 over 30 days. Average 30-day sentiment is 61.4/100. No insider transactions filed in the last 90 days. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
4
avg sentiment 58.5/100
30d stories
10
avg sentiment 61.4/100
Insider net (90d)
$0
0 buys · 0 sells
Congress (90d)
0
0 buys · 0 sells

KYTX news in the last 24 hours, 7 days, 30 days and 90 days

How much KYTX coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowKYTX storiesAvg AI sentimentRead
Last 24 hours0—no coverage
Last 7 days458.5/100KYTX headlines →
Last 30 days1061.4/100KYTX headlines →
Last 90 days2761/100KYTX headlines →

Latest stories on KYTX

2d ago
7d ago
7d ago
7d ago
Oct 22
Oct 21
Oct 21
Oct 7
Oct 7
Oct 5
H.C. Wainwright reiterates Kyverna stock rating on durability data
Investing.com Analyst Ratings56 · neutralanalyst
Sep 25
Sep 24
Kyverna stock jumps on positive one-year therapy data
Investing.com Markets71 · bullishproduct/pr
Sep 24
Sep 24
Why is Kyverna Therapeutics stock surging today?
Investing.com Markets65 · bullishgeneral
Sep 24
Sep 24
Sep 24
Sep 24
Sep 15
Sep 2
Sep 2
Aug 13
Aug 11
Aug 11
Aug 11
Open KYTX in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →